Clinical Trials & New Treatment Strategies

Pictured: Richard O'Reilly Richard O'Reilly, Chair of the Department of Pediatrics, has pioneered and continues to lead the development of innovative treatments for childhood cancers.

As a patient at Memorial Sloan Kettering, your child or young adult may be able to participate in a clinical research study, also known as a clinical trial. In a clinical trial, doctors evaluate a new therapy or a therapy combination to determine whether it is more effective than the current best approaches.

Information learned through clinical trials has helped raise the cure rate for pediatric cancers to more than 70 percent overall, with some childhood malignancies achieving more than 90 percent cure rates. Clinical trials test the newest, most-effective possible approaches to the treatment of these diseases, with the intent to provide long-term disease-free survival in all children with cancer.

Our patients have access to many of the latest clinical trials, some of which are only available at Memorial Sloan Kettering. We also participate in many nationwide clinical trials as a founding member of the Children’s Oncology Group, as the coordinating center and co-founder of the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium, and through other multicenter trial networks across the United States.

The decision to have your child participate in a clinical trial is entirely up to you and your child. Regardless of whether your child receives standard treatment or therapy through a clinical trial, he or she will benefit from Memorial Sloan Kettering’s ongoing commitment to excellence in patient care.